Forte Biosciences, Inc. · NASDAQ:FBRX
TYBOURNE CAPITAL MANAGEMENT (HK) LTD reported a 9.99% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
TYBOURNE CAPITAL MANAGEMENT (HK) LTD reported a 9.99% stake in Forte Biosciences, Inc., 640,770 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 640,770
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 9.99% | 640,770 |
| TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED | 9.99% | 640,770 |
| Tybourne Capital Management Ltd | 9.99% | 640,770 |
| Tybourne Kesari Ltd | 9.99% | 640,770 |
| Krishnan Viswanathan | 9.99% | 640,770 |
Source
Related
- Forte Biosciences, Inc.
- Tybourne Capital Management (Hk) LTD
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Tybourne Capital Management (Hk) LTD · Aug 4, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026